ICU Medical (NASDAQ:ICUI) Downgraded to “Hold” Rating by StockNews.com

ICU Medical (NASDAQ:ICUI) was downgraded by investment analysts at StockNews.com from a “buy” rating to a “hold” rating in a research note issued on Monday.

Several other equities analysts also recently weighed in on the company. Needham & Company LLC reaffirmed a “hold” rating on shares of ICU Medical in a research report on Wednesday, November 13th. KeyCorp boosted their price objective on ICU Medical from $198.00 to $209.00 and gave the stock an “overweight” rating in a research report on Wednesday, November 13th. Finally, Jefferies Financial Group raised ICU Medical from a “hold” rating to a “buy” rating and set a $200.00 price target for the company in a report on Wednesday, December 11th. Two analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $199.67.

ICU Medical Trading Down 8.4 %

ICUI traded down $11.92 on Monday, hitting $130.05. The company had a trading volume of 530,532 shares, compared to its average volume of 227,338. The firm has a market cap of $3.19 billion, a P/E ratio of -28.46 and a beta of 0.73. ICU Medical has a 1 year low of $93.36 and a 1 year high of $196.26. The company’s fifty day moving average price is $158.56 and its 200 day moving average price is $165.59. The company has a current ratio of 2.29, a quick ratio of 1.03 and a debt-to-equity ratio of 0.75.

Insider Activity at ICU Medical

In related news, CEO Vivek Jain sold 1,373 shares of the business’s stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $155.48, for a total transaction of $213,474.04. Following the transaction, the chief executive officer now directly owns 104,593 shares of the company’s stock, valued at approximately $16,262,119.64. The trade was a 1.30 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Corporate insiders own 6.70% of the company’s stock.

Hedge Funds Weigh In On ICU Medical

Institutional investors have recently made changes to their positions in the business. Amalgamated Bank increased its holdings in shares of ICU Medical by 13.1% in the 3rd quarter. Amalgamated Bank now owns 7,067 shares of the medical instruments supplier’s stock valued at $1,288,000 after acquiring an additional 816 shares during the last quarter. Principal Financial Group Inc. grew its stake in ICU Medical by 24.6% during the 3rd quarter. Principal Financial Group Inc. now owns 126,937 shares of the medical instruments supplier’s stock worth $23,130,000 after buying an additional 25,031 shares during the last quarter. Atria Investments Inc bought a new position in ICU Medical during the 3rd quarter worth $228,000. Crossmark Global Holdings Inc. bought a new position in ICU Medical during the 3rd quarter worth $313,000. Finally, Venturi Wealth Management LLC boosted its position in ICU Medical by 1,510.0% during the 3rd quarter. Venturi Wealth Management LLC now owns 322 shares of the medical instruments supplier’s stock worth $59,000 after acquiring an additional 302 shares during the period. 96.10% of the stock is owned by institutional investors and hedge funds.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.